News
BioGenes Berlin

Our Affinity Purification Strategy

At BioGenes, we elevate immunogenicity testing with dual-step affinity chromatography, isolating specific anti-idiotypic (anti-ID) antibodies while depleting human IgGs.

Why it matters?

✅ Enhanced Specificity: Only relevant anti-ID antibodies remain
✅ Reduced Background: Minimizes false positives for reliable ELISA results
✅ Improved Quantification: Accurate ADA measurement for biopharma monitoring

Our process delivers two high-purity fractions and undergoes strict ELISA quality control, powering soluble bridging assays with exceptional sensitivity.
Precision and innovation drive our solutions for biopharma needs.
 

Newsletter

Keep me updated 

Subscribe